Strong Statins as the Major Players for Dyslipidemia in High-Risk Patients–Are They All the Same or Not?–
K Ikewaki, M Ayaori - Circulation Journal, 2011 - jstage.jst.go.jp
1327 Comparative Study of 3 Strong Statins ferase (ALT) was observed more frequently with
atorvastatin than with the other 2 statins. Although this significant difference diluted toward …
atorvastatin than with the other 2 statins. Although this significant difference diluted toward …
[PDF][PDF] Strong Statins as the Major Players for Dyslipidemia in High-Risk Patients
K Ikewaki, M Ayaori - Circulation Journal, 2011 - scholar.archive.org
1327 Comparative Study of 3 Strong Statins ferase (ALT) was observed more frequently with
atorvastatin than with the other 2 statins. Although this significant difference diluted toward …
atorvastatin than with the other 2 statins. Although this significant difference diluted toward …
[引用][C] Strong Statins as the Major Players for Dyslipidemia in High-Risk Patients–Are They All the Same or Not?–
K Ikewaki, M Ayaori - Circulation Journal, 2011 - jstage.jst.go.jp
Advance Publication by J-STAGE ferase (ALT) was observed more frequently with
atorvastatin than with the other 2 statins. Although this significant difference diluted toward …
atorvastatin than with the other 2 statins. Although this significant difference diluted toward …
[引用][C] Strong statins as the major players for dyslipidemia in high-risk patients: are they all the same or not?
K Ikewaki, M Ayaori - Circulation journal: official journal of …, 2011 - pubmed.ncbi.nlm.nih.gov
Strong statins as the major players for dyslipidemia in high-risk patients: are they all the same
or not? Strong statins as the major players for dyslipidemia in high-risk patients: are they all the …
or not? Strong statins as the major players for dyslipidemia in high-risk patients: are they all the …
Strong statins as the major players for dyslipidemia in high-risk patients: are they all the same or not?
K Ikewaki, M Ayaori - Circulation Journal: Official Journal of the …, 2011 - europepmc.org
Strong statins as the major players for dyslipidemia in high-risk patients: are they all the same
or not? - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …
or not? - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …
Strong Statins as the Major Players for Dyslipidemia in High-Risk Patients
K Ikewaki, M Ayaori - Circulation Journal, 2011 - jlc.jst.go.jp
1327 Comparative Study of 3 Strong Statins ferase (ALT) was observed more frequently with
atorvastatin than with the other 2 statins. Although this significant difference diluted toward …
atorvastatin than with the other 2 statins. Although this significant difference diluted toward …
Strong Statins as the Major Players for Dyslipidemia in High-Risk Patients
K Ikewaki, M Ayaori - Circulation Journal, 2011 - jlc.jst.go.jp
1327 Comparative Study of 3 Strong Statins ferase (ALT) was observed more frequently with
atorvastatin than with the other 2 statins. Although this significant difference diluted toward …
atorvastatin than with the other 2 statins. Although this significant difference diluted toward …